Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 3M, Lumora in BART Technology Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

3M, Lumora in BART Technology Pact

3M to develop and sell nucleic acid test kits

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lumora Ltd. and 3M have signed a joint development and licensing agreement, under which 3M will develop and sell nucleic acid test kits using Lumora’s BART technology.

Lumora specializes in the development of “robust, affordable and easy-to use molecular diagnostics systems,” based on its BART (Bioluminescent Assay in Real-Time) technology. BART is a reporter system for use with isothermal nucleic acid amplification technologies, and is used as a tool in molecular diagnostics. The company, founded in 2002 as a spin-out from the Institute of Biotechnology at the University of Cambridge, operates from a dedicated, 6,100-sq.-ft. facility with capabilities that include bioinformatics, primer design, test optimization, test evaluation, protocol optimization, reagent stabilization and scale-up guidance.   

Lumora is seeking other collaborative development and licensing partners to bring its technology to market in industrial sectors and clinical in vitro diagnostic applications.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters